Clinical Trials Logo

Filter by:
NCT ID: NCT04929197 Enrolling by invitation - Breast Cancer Clinical Trials

Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing

PERSBRA
Start date: April 21, 2016
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT04872933 Enrolling by invitation - Clinical trials for Chronic Kidney Diseases

The Kidney BEAM Trial

Start date: April 21, 2021
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT04151602 Enrolling by invitation - Tuberculosis Clinical Trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages

TOTAL
Start date: April 22, 2021
Phase:
Study type: Observational
Read more »
NCT ID: NCT05865925 Enrolling by invitation - Clinical trials for Advanced Solid Tumors

Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors

Start date: April 22, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open, dose escalation, single and multiple administration phase Ⅰ/Ⅱ clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and primary clinical efficacy of LY01616 in patients with advanced solid tumors

NCT ID: NCT05337579 Enrolling by invitation - Clinical trials for Musculoskeletal Pain

Combined Effects of Exercise Breaks and Rest Breaks on Fatigue and Musculoskeletal Discomfort in Static Workstation Office Workers

Start date: April 22, 2022
Phase: N/A
Study type: Interventional

Musculoskeletal discomfort and work fatigue has enormous impact on quality of personal and professional life and increases health related economic burden on country due to increased cost of healthcare and reduced productivity in work. Upper limb and neck pain complains are the most frequent when evaluated in computer workers. The incidence of musculoskeletal discomfort in office workers is as high as 50%. While fatigue is also common due to its high prevalence and its relationship with dysfunctional disorders in office workers. The objective of this study is to compare and determine the effects of exercise breaks, rest breaks and exercise along with rest breaks on Fatigue and Musculoskeletal discomfort in static workstation office workers

NCT ID: NCT06276556 Enrolling by invitation - Gout Clinical Trials

Extension Study of ABP-671 in Participants With Gout

Start date: April 22, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objectives of this study are to assess the safety, tolerability, and efficacy of ABP-671 in lowering serum uric acid (sUA) in participants with gout who roll over from Study ABP-671-301 after they complete the double-blind 28-week Treatment Period of Part 1 (Phase 2b) or Part 2 (Phase 3).

NCT ID: NCT06437886 Enrolling by invitation - Clinical trials for Cardiac Surgery Patients

High-dose Opioid Versus Opioid-sparing Anaesthesia in Cardiac Surgery

Start date: April 22, 2024
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT06443411 Enrolling by invitation - Clinical trials for Normal Tension Glaucoma

R&D of Non-invasive Innovative Intracranial Waves Monitoring System for Diagnostics and Treatment Monitoring of Patients With Normal Tension Glaucoma

Start date: April 22, 2024
Phase:
Study type: Observational
Read more »
NCT ID: NCT04346680 Enrolling by invitation - Clinical trials for Neurotmesis of Peripheral Nerve (Disorder)

Intraoperative ADSC Administration During Nerve Release

NEUROASC
Start date: April 23, 2014
Phase: N/A
Study type: Interventional

The goal of the investigator's observational, nonrandomized, open label study is to investigate the safety and efficacy of autologous adipose derived mesenchymal cells (ADSC) transplantation into the individuals with faiure in reconstruction of peripheral nerves. ADSC will be used during a last-chance surgery (neurolysis, nerve release) on a previously reconstructed nerve. All enrolled patients will have a documented at least 2-years clinical and electrophisiological observation. Each patient will recive once 10 microinjections of ADSC along the injured nerve, directly after nerve neurolysis. Safety, adverse events and efficacy will be confirmed by clinical, elecrophisiological (EMG, Sensory Thyreshold) and DASH survey.

NCT ID: NCT03070613 Enrolling by invitation - Colorectal Cancer Clinical Trials

Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery

Start date: April 23, 2017
Phase: Early Phase 1
Study type: Interventional

This is a feasibility study investigating the use of a fluorescently conjugated lectin to identify colorectal dysplasia and cancer during colonoscopy and surgery.